Oak Street Health

The momentum for this stock is not very good. Oak Street Health is not a good value stock. Oak Street Health is not very popular among insiders. Tradey thinks it is not wise to invest in Oak Street Health.
Log in to see more information.

News

Critical Survey: Oak Street Health (NYSE:OSH) & GeneDx (NASDAQ:WGS)
Critical Survey: Oak Street Health (NYSE:OSH) & GeneDx (NASDAQ:WGS)

Zolmax Oak Street Health (NYSE:OSH Get Rating) and GeneDx (NASDAQ:WGS Get Rating) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, risk ...\n more…

Oak Street Health, Inc. (NYSE:OSH) Receives $32.92 Consensus Target Price from Brokerages
Oak Street Health, Inc. (NYSE:OSH) Receives $32.92 Consensus Target Price from Brokerages

Ticker Report Shares of Oak Street Health, Inc. (NYSE:OSH Get Rating) have received a consensus recommendation of Hold from the twenty ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, ...\n more…

Oak Street Health (NYSE:OSH) & GeneDx (NASDAQ:WGS) Financial Comparison
Oak Street Health (NYSE:OSH) & GeneDx (NASDAQ:WGS) Financial Comparison

Ticker Report Oak Street Health (NYSE:OSH Get Rating) and GeneDx (NASDAQ:WGS Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, dividends, risk, institutional ownership, ...\n more…

CVS Health's Sales Rise 11%; Oak Street Health, Signify Health Acquisitions Close
CVS Health's Sales Rise 11%; Oak Street Health, Signify Health Acquisitions Close

Yahoo! Finance: News CVS Health posted higher revenue in the first quarter but downgraded its earnings projection for the year because of the impact of its biggest deals since the nearly $70 billion takeover of Aetna in 2018.\n more…

CVS Bolsters Primary Care With Completion Of $10.6 Billion Oak Street Health Deal
CVS Bolsters Primary Care With Completion Of $10.6 Billion Oak Street Health Deal

Forbes.com: Healthcare News CVS Health completed its acquistion of Oak Street Health for $10.6 billion in cash, adding a large network of doctor-staffed clinics primarily used by seniors.CVS Health completed its acquistion of Oak Street Health for $10.6 billion in cash, adding a large network of doctor-staffed clinics ...\n more…

Oppenheimer Asset Management Inc. Acquires 4,103 Shares of Oak Street Health, Inc. (NYSE:OSH)
Oppenheimer Asset Management Inc. Acquires 4,103 Shares of Oak Street Health, Inc. (NYSE:OSH)

Zolmax Oppenheimer Asset Management Inc. boosted its holdings in shares of Oak Street Health, Inc. (NYSE:OSH Get Rating) by 3.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 139,682 shares of the companys stock after ...\n more…